📊 Full opportunity report: Vertigo relief app on IdeaNavigator AI — validation score, market gap, and execution plan.
TL;DR
A new vertigo relief app is being developed to assist adults with BPPV in managing their condition at home. It uses motion sensors and guided exercises, with potential for clinic integration. Validation efforts are underway to gauge user engagement and clinical interest.
An iOS and Android vertigo relief app is in early development to assist adults suffering from recurrent benign paroxysmal positional vertigo (BPPV). The app aims to guide users through repositioning maneuvers like the Epley, using real-time gyroscope feedback, and log symptoms over time. It is targeted at both consumers and ENT clinics, audiologists, and vestibular physiotherapists, with testing and validation efforts currently underway. More information about vestibular therapy tools can be found in this guest app with day-of seating lookup and schedule. This development responds to the growing demand for accessible, home-based vestibular therapy amid rising telehealth adoption. For recent updates on telehealth services, see DoorDash App Outage.
The proposed mobile app will feature a screening tool for BPPV candidacy, including a safety survey and optional motion-sensor self-check. It will provide animated, step-by-step guidance for maneuvers such as the Epley and Brandt-Daroff, supplemented by audio cues and gyroscope-based head-angle feedback to ensure correct positioning. Users will be able to log dizziness episodes, triggers, and severity, creating a symptom history for better management. The app will include a disclaimer clarifying it is not a substitute for medical advice, urging users to consult healthcare providers if red-flag symptoms occur.
Potential Impact on Vestibular Self-Management
This app development addresses a significant gap in home-based management of BPPV, the most common vestibular disorder. With long wait times for specialist care and challenges in performing repositioning maneuvers correctly from static diagrams, many patients self-treat improperly, risking relapse. By providing guided, sensor-supported exercises, the app could improve treatment accuracy, reduce recurrence rates, and enable continuous symptom tracking. Its integration into clinical workflows could also extend the reach of vestibular rehabilitation outside of clinics, especially as telehealth and digital therapeutics grow.
DizzyFIX Vertigo Relief Trainer for Benign Paroxysmal Positional Vertigo or BPPV, Inner Ear Balance Device for Particle Repositioning Maneuver, Non-Drug Solution & Relieves Dizziness
REGAIN INNER EAR BALANCE: The DizzyFIX Vertigo Relief Trainer is a revolutionary device that can help people suffering…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Growing Market and Telehealth Trends Accelerate Development
The push for digital therapeutics in vestibular care is driven by increased telehealth adoption, accelerated by the COVID-19 pandemic. Smartphones now include accurate motion sensors capable of measuring head angles in real time, enabling new self-management tools. The digital vestibular rehabilitation market was valued near USD 498 million in 2024, with a projected compound annual growth rate of approximately 13.5% through 2033, reflecting rising acceptance among both patients and payers. These trends create a favorable environment for the app’s introduction and adoption.
“The app aims to leverage smartphone sensors to guide patients through proper repositioning, reducing improper self-treatment and improving outcomes.”
— an anonymous researcher
vestibular therapy sensor device
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Uncertainties About User Engagement and Clinical Adoption
It remains unclear how many users will adopt the app during initial testing phases, and whether clinics will actively recommend it for patient home care. The effectiveness of gyroscope-guided exercises and user compliance over time are still being evaluated. Additionally, regulatory and reimbursement pathways for such digital therapeutics are evolving, which could influence broader adoption.
Rock Steady
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps Include User Testing and Clinic Trials
The development team plans to launch a landing page and a no-code guided Epley maneuver demo to measure interest via email signups and completion rates. Simultaneously, they will pitch ENT, audiology, and physiotherapy clinics to trial the app with patients, assessing clinical demand and integration feasibility. Further updates on user feedback and regulatory progress are expected in the coming months.
Epley maneuver guide app
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does the app guide users through maneuvers?
The app provides animated, step-by-step instructions accompanied by audio cues, and uses gyroscope sensors in smartphones to give real-time head-angle feedback for correct positioning.
Is the app a substitute for seeing a healthcare professional?
No, the app includes a clear disclaimer stating it is not a substitute for medical advice. Users are encouraged to consult a healthcare provider if symptoms worsen or red-flag symptoms appear.
When will the app be available for download?
Development is still in early stages, with testing and validation ongoing. A public release date has not yet been announced.
Will clinics be able to recommend the app to patients?
Yes, part of the plan is to enable ENT clinics, audiologists, and physiotherapists to license or white-label the app for patient home programs, pending successful trials and regulatory approval.
How will the app track symptoms over time?
Users can log dizziness episodes, triggers, and severity, creating a history that can help inform ongoing management and potentially shared with healthcare providers.
Source: IdeaNavigator AI
